Home >> Healthcare >> Oral Antiparkinsonian Drugs Market

Global Oral Antiparkinsonian Drugs Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 850 | Pages : 141 | Oct 2024

Report Overview

Oral antiparkinsonian drugs are medications taken by mouth to manage the symptoms of Parkinson's disease, a neurodegenerative disorder characterized by tremors, stiffness, slow movement, and balance problems. These drugs aim to restore the balance of dopamine and other neurotransmitters in the brain, thereby improving motor function and quality of life for patients. Common oral antiparkinsonian medications include levodopa (often combined with carbidopa to enhance its effectiveness), dopamine agonists (such as pramipexole and ropinirole), MAO-B inhibitors (like selegiline and rasagiline), and anticholinergics (such as benztropine). Each drug works differently, and treatment is typically tailored to the individual's specific symptoms and disease progression, often involving a combination of medications to achieve optimal control of Parkinson's symptoms.

The global Oral Antiparkinsonian Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

Analytic Insights Hub ' newest research report, the “Oral Antiparkinsonian Drugs Industry Forecast” looks at past sales and reviews total world Oral Antiparkinsonian Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Antiparkinsonian Drugs sales for 2024 through 2030. With Oral Antiparkinsonian Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Antiparkinsonian Drugs industry.

This Insight Report provides a comprehensive analysis of the global Oral Antiparkinsonian Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Antiparkinsonian Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Antiparkinsonian Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Antiparkinsonian Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Antiparkinsonian Drugs.

United States market for Oral Antiparkinsonian Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Oral Antiparkinsonian Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Oral Antiparkinsonian Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Oral Antiparkinsonian Drugs players cover AbbVie, Merck, Boehringer Ingelheim, GlaxoSmithKline, Novartis Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antiparkinsonian Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    L-Dopa Formulations
    Dopamine Agonists
    Mao-B Inhibitors
    COMT Inhibitors

Segmentation by Application:
    Under 40 Years Old
    40-65 Years Old
    Above 65 Years Old

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    AbbVie
    Merck
    Boehringer Ingelheim
    GlaxoSmithKline
    Novartis Pharma
    Supernus Pharmaceuticals
    Bausch Health
    Newron Pharmaceuticals
    Teva Pharmaceutica
    Glenmark Pharmaceuticals
    Orion Pharma
    Neurocrine Biosciences
    Kyowa Kirin
    UCB
    Desitin Arzneimittel
    Amneal Pharmaceuticals
    Organon Pharma
    F.Hoffmann-La Roche
    Lundbeck
    Stada

Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Antiparkinsonian Drugs market?
What factors are driving Oral Antiparkinsonian Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Antiparkinsonian Drugs market opportunities vary by end market size?
How does Oral Antiparkinsonian Drugs break out by Type, by Application?

Frequently Asked Questions?

Ans - The purpose of a Oral Antiparkinsonian Drugs market research report is to provide data-driven insights and analysis on a Oral Antiparkinsonian Drugs market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Oral Antiparkinsonian Drugs market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.